Status:

COMPLETED

Comparison of Quality of Life After Discharge of the Mild and Moderate COVID-19 Patients With or Without Herbal Medicine

Lead Sponsor:

University of Medicine and Pharmacy at Ho Chi Minh City

Conditions:

COVID-19 Pandemic

Quality of Life

Eligibility:

All Genders

18-64 years

Brief Summary

The purpose of this study is to see how the acute stage COVID-19 treatments by use of herbal medicine (Shen Cao Gan Jiang Tang) affect quality of life and symptoms at 3 months after hospital discharge...

Detailed Description

According to the theory of Traditional medicine, the patient will suffer damage to Qi and Fluid in the acute phase and lead to damaged Yin and Qi in the post COVID-19 period. The Shen Cao Gan Jiang T...

Eligibility Criteria

Inclusion

  • Patients able to understand and fill out a questionnaire
  • From full 18 to 64 years old;
  • Patients with the mild and moderate COVID-19 who used Shen Cao Gan Jiang Tang in the acute phase for intervention group.
  • Participants enrolled in protocol NCT05055427.
  • Voluntarily consented to participate in the study

Exclusion

  • Patient who are not able to complete 100% of the questionnaire Criteria for stopping the study
  • The patient cannot be contacted after 04 calls, each call is at least 06 hours apart on the survey days.
  • The patient does not want to continue participating in the study.

Key Trial Info

Start Date :

December 20 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 20 2023

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT05228873

Start Date

December 20 2021

End Date

January 20 2023

Last Update

July 28 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Medicine and Pharmacy at Ho Chi Minh City

Ho Chi Minh City, Vietnam, 700000